NCT07591467: Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer
- State
- Not started
- Phase
- Phase 3
- People
- 330 planned
- Started
- Sep 2026
- Primary completion
- Sep 2036
- Arms
- Experimental arm
- Results
- None posted
- 15 May 2026: Trial registered